3',4'-dihydroxyflavone has been researched along with glucose, (beta-d)-isomer in 1 studies
| Studies (3',4'-dihydroxyflavone) | Trials (3',4'-dihydroxyflavone) | Recent Studies (post-2010) (3',4'-dihydroxyflavone) | Studies (glucose, (beta-d)-isomer) | Trials (glucose, (beta-d)-isomer) | Recent Studies (post-2010) (glucose, (beta-d)-isomer) |
|---|---|---|---|---|---|
| 31 | 0 | 14 | 21,956 | 883 | 10,747 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gebhardt, R; Giesa, S; Schlupper, D | 1 |
1 other study(ies) available for 3',4'-dihydroxyflavone and glucose, (beta-d)-isomer
| Article | Year |
|---|---|
Influence of biotransformation of luteolin, luteolin 7-O-glucoside, 3',4'-dihydroxyflavone and apigenin by cultured rat hepatocytes on antioxidative capacity and inhibition of EGF receptor tyrosine kinase activity.
Topics: Animals; Antioxidants; Apigenin; Biotransformation; Cells, Cultured; ErbB Receptors; Flavonoids; Glucosides; Hepatocytes; Luteolin; Rats; Rats, Sprague-Dawley | 2006 |